Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1381 AL 1395

Comparison of zonisamide with non-levodopa, anti-Parkinson's disease drugs in the incidence of Parkinson's disease-relevant symptoms

Iwaki H, Tagawa M, Iwasaki K, Kawakami K, Nomoto M.

J Neurol Sci. 2019 Jul 15;402:145-152. doi: 10.1016/j.jns.2019.05.028. Epub 2019 May 24.

Zebrafish as an Emerging Model for Bioassay-Guided Natural Product Drug Discovery for Neurological Disorders

Pitchai A, Rajaretinam RK, Freeman JL.

Medicines (Basel). 2019 May 30;6(2):61. doi: 10.3390/medicines6020061.

Trend and risk factors of recurrence and complications after arrhythmias radiofrequency catheter ablation: a nation-wide observational study in Taiwan

Lin Y, Wu HK, Wang TH, Chen TH, Lin YS.

BMJ Open. 2019 May 30;9(5):e023487. doi: 10.1136/bmjopen-2018-023487.

Biofilm reactors as a promising method for vitamin K (menaquinone-7) production

Mahdinia E, Demirci A, Berenjian A.

Appl Microbiol Biotechnol. 2019 Jul;103(14):5583-5592. doi: 10.1007/s00253-019-09913-w. Epub 2019 Jun 1.

Spreading of alpha-synuclein - relevant or epiphenomenon?

Killinger BA, Kordower JH.

J Neurochem. 2019 Sep;150(5):605-611. doi: 10.1111/jnc.14779. Epub 2019 Jul 9.

Prospective cohort study of patients with early gastric cancer to detect prodromal Parkinson disease (EGC-PPD): A study protocol and baseline characteristics

Shin C, Yang HK, Park S, Lee HJ, Kong SH, Suh YS, Huh YJ, Kim YJ, Park SY, Ahn TB, Lee SH, Kim HJ, Jeon B.

J Clin Neurosci. 2019 Aug;66:26-32. doi: 10.1016/j.jocn.2019.05.033. Epub 2019 May 29.

NanoCsA improves the survival of human iPSC transplant in hemiparkinsonian rats

Yu SJ, Wang YC, Chang CY, Hsieh W, Chen S, Yang CS, Lin SZ, Wang Y.

Brain Res. 2019 Sep 15;1719:124-132. doi: 10.1016/j.brainres.2019.05.040. Epub 2019 May 30.

Oxidative stress and Parkinson's disease: conflict of oxidant-antioxidant systems

Hemmati-Dinarvand M, Saedi S, Valilo M, Kalantary-Charvadeh A, Alizadeh Sani M, Kargar R, Safari H, Samadi N.

Neurosci Lett. 2019 Sep 14;709:134296. doi: 10.1016/j.neulet.2019.134296. Epub 2019 May 30.

Quantitatively validating the efficacy of artifact suppression techniques to study the cortical consequences of deep brain stimulation with magnetoencephalography

Boring MJ, Jessen ZF, Wozny TA, Ward MJ, Whiteman AC, Richardson RM, Ghuman AS.

Neuroimage. 2019 Oct 1;199:366-374. doi: 10.1016/j.neuroimage.2019.05.080. Epub 2019 May 31.

Using global team science to identify genetic parkinson's disease worldwide

Vollstedt EJ, Kasten M, Klein C; MJFF Global Genetic Parkinson's Disease Study Group.

Ann Neurol. 2019 Aug;86(2):153-157. doi: 10.1002/ana.25514. Epub 2019 Jun 26.

Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's disease

Pagano G, Niccolini F, Wilson H, Yousaf T, Khan NL, Martino D, Plisson C, Gunn RN, Rabiner EA, Piccini P, Foltynie T, Politis M.

Mov Disord. 2019 Oct;34(10):1505-1515. doi: 10.1002/mds.27733. Epub 2019 Jun 3.

Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods

Tuffaha GO, Hatmal MM, Taha MO.

J Mol Graph Model. 2019 Sep;91:30-51. doi: 10.1016/j.jmgm.2019.05.015. Epub 2019 May 23.

A frontline defense against neurodegenerative diseases:the development of early disease detection methods

Baldacci F, Lista S, Vergallo A, Palermo G, Giorgi FS, Hampel H.

Expert Rev Mol Diagn. 2019 Jul;19(7):559-563. doi: 10.1080/14737159.2019.1627202. Epub 2019 Jun 10.

Changing the treatment paradigm for Parkinson's disease psychosis with pimavanserin

Lyons KE, Pahwa R, Hermanowicz N, Davis T, Pagan F, Isaacson S.

Expert Rev Clin Pharmacol. 2019 Jul;12(7):681-691. doi: 10.1080/17512433.2019.1623669. Epub 2019 Jun 13.

Pearls & Oy-sters: CAA-related inflammation presents as subacute cognitive decline in a patient with Parkinson disease

Gera A, Witek N, Bailey M.

Neurology. 2019 Jun 4;92(23):1116-1118. doi: 10.1212/WNL.0000000000007610.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias